Creative Planning’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-923
| Closed | -$3.19K | – | 3566 |
|
|
2024
Q3 | $3.19K | Sell |
923
-472
| -34% | -$1.63K | ﹤0.01% | 3181 |
|
|
2024
Q2 | $7.08K | Sell |
1,395
-53
| -4% | -$269 | ﹤0.01% | 2982 |
|
|
2024
Q1 | $12.3K | Buy |
1,448
+47
| +3% | +$398 | ﹤0.01% | 2827 |
|
|
2023
Q4 | $5.74K | Buy |
1,401
+325
| +30% | +$1.33K | ﹤0.01% | 2708 |
|
|
2023
Q3 | $3.23K | Hold |
1,076
| – | – | ﹤0.01% | 2716 |
|
|
2023
Q2 | $33.2K | Buy |
1,076
+143
| +15% | +$4.42K | ﹤0.01% | 2449 |
|
|
2023
Q1 | $46.2K | Sell |
933
-779
| -46% | -$38.6K | ﹤0.01% | 2331 |
|
|
2022
Q4 | $42.1K | Sell |
1,712
-333
| -16% | -$8.19K | ﹤0.01% | 2230 |
|
|
2022
Q3 | $136K | Buy |
+2,045
| New | +$136K | ﹤0.01% | 1972 |
|
|
2021
Q1 | – | Sell |
-2,413
| Closed | -$164K | – | 2339 |
|
|
2020
Q4 | $164K | Buy |
2,413
+680
| +39% | +$46.2K | ﹤0.01% | 1911 |
|
|
2020
Q3 | $440K | Sell |
1,733
-334
| -16% | -$84.8K | ﹤0.01% | 1180 |
|
|
2020
Q2 | $348K | Buy |
+2,067
| New | +$348K | ﹤0.01% | 1209 |
|
|
2017
Q1 | – | Sell |
-67
| Closed | -$3K | – | 4494 |
|
|
2016
Q4 | $3K | Hold |
67
| – | – | ﹤0.01% | 4031 |
|
|
2016
Q3 | $2K | Hold |
67
| – | – | ﹤0.01% | 4079 |
|
|
2016
Q2 | $2K | Hold |
67
| – | – | ﹤0.01% | 3884 |
|
|
2016
Q1 | $3K | Hold |
67
| – | – | ﹤0.01% | 3721 |
|
|
2015
Q4 | $3K | Hold |
67
| – | – | ﹤0.01% | 3804 |
|
|
2015
Q3 | $2K | Buy |
+67
| New | +$2K | ﹤0.01% | 3847 |
|
|
2015
Q2 | – | Sell |
-67
| Closed | -$4K | – | 1225 |
|
|
2015
Q1 | $4K | Buy |
+67
| New | +$4K | ﹤0.01% | 3538 |
|